Artículos Científicos

DATE: 2018/08/30
Publisher Correction: Alcoholic liver disease
Nat Rev Dis Primers. 2018 Aug 28;4(1):18. doi: 10.1038/s41572-018-0021-8.
AUTHORS: Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H.
PMID: 30154473
DATE: 2018/08/23
A Survey on the Medical Use of Cannabis in Europe: A Position Paper
Eur Addict Res. 2018;24(4):201-205. doi: 10.1159/000492757. Epub 2018 Aug 22.
AUTHORS: Bramness JG, Dom G, Gual A, Mann K, Wurst FM.
PMID: 30134238
DATE: 2018/08/18
Alcoholic liver disease
Nat Rev Dis Primers. 2018 Aug 16;4(1):16. doi: 10.1038/s41572-018-0014-7.
AUTHORS: Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, Mathurin P, Mueller S, Szabo G, Tsukamoto H.
PMID: 30115921
DATE: 2018/07/31
A comparison between phase-III trials and a phase-IV study of nalmefene in alcohol use disorder patients. Is there a difference?
Adicciones. 2019 Sep 1;31(4):284-288. doi: 10.20882/adicciones.1046.
AUTHORS: Barrio Giménez P, Ortega L, Guardia J, Roncero C, Yuguero L, Gual A.
PMID: 30059574
DATE: 2018/07/31
Role of Alcohol and Drug Detection by Regular Urine Sample Testing in pre-transplant evaluation for Alcohol Liver Disease
Adicciones. 2020 Nov 17;32(4):243-254. doi: 10.20882/adicciones.1121.
AUTHORS: López-Pelayo H, Altamirano J, López E, Barrio P, López A, Gual A, Lligoña A.
PMID: 30059586
DATE: 2018/07/31
Quality of life role in risky alcohol use research: should it be a more relevant outcome in any study?
Adicciones. 2018 Jul 13;30(4):301-303. doi: 10.20882/adicciones.1098.
AUTHORS: López-Pelayo H, Oliveras C, Segura L, Colom J, Díaz E, Wallace P, Gual A.
PMID: 30059591
DATE: 2018/07/26
Efficacy and safety of sodium oxybate in alcohol-dependent patients with a very high drinking risk level
Addict Biol. 2018 Jul;23(4):969-986. doi: 10.1111/adb.12645.
AUTHORS: van den Brink W, Addolorato G, Aubin HJ, Benyamina A, Caputo F, Dematteis M, Gual A, Lesch OM, Mann K, Maremmani I, Nutt D, Paille F, Perney P, Rehm J, Reynaud M, Simon N, Söderpalm B, Sommer WH, Walter H, Spanagel R.
PMID: 30043457
DATE: 2018/06/28
Quantitative Criteria to Screen for Cannabis Use Disorder
Eur Addict Res. 2018;24(3):109-117. doi: 10.1159/000488346. Epub 2018 Jun 27.
AUTHORS: Casajuana C, López-Pelayo H, Miquel L, Balcells-Oliveró MM, Colom J, Gual A.
PMID: 29949807
DATE: 2018/05/31
Optimizing the delivery of interventions for harmful alcohol use in primary healthcare: an update
Curr Opin Psychiatry. 2018 Jul;31(4):324-332. doi: 10.1097/YCO.0000000000000435.
AUTHORS: Segura L, Anderson P, Gual A.
PMID: 29846264
DATE: 2018/05/11
Reducing the health risks derived from exposure to addictive substances
Curr Opin Psychiatry. 2018 Jul;31(4):333-341. doi: 10.1097/YCO.0000000000000432.
AUTHORS: Anderson P, Gual A, Rehm J.
PMID: 29746421